TABLE 2.
Infected (N = 113) | Sterile (N = 45) | P | |
---|---|---|---|
Males | 70 (61.9%) | 27 (60.0%) | 0.821 |
Age | 59.2 (±14.4) | 53.9 (±16.5) | 0.065 |
APACHE II | 10.5 (±6.4) | 7.9 (±5.6) | 0.014 |
Organ failure | 49 (43.4%) | 17 (37.8%) | 0.521 |
Preoperative antibiotic therapy | 98 (86.7%) | 36 (80.0%) | 0.288 |
Days from onset of symptoms to surgery | 44 (±44.8) | 64.5 (±72.2) | 0.082 |
Postoperative ICU | 72 (63.7%) | 20 (44.4%) | 0.027 |
Pancreatic fistula | 45 (39.8%) | 15 (33.3%) | 0.448 |
Enteric fistula | 21 (18.6%) | 3 (6.7%) | 0.84 |
Intra-abdominal hemorrhage | 6 (5.3%) | 0 (0.0%) | 0.184 |
Wound infection | 24 (21.2%) | 2 (4.4%) | 0.009 |
Other major complication | 7 (6.2%) | 1 (2.2%) | 0.442 |
Postoperative IR drain | 34 (30.1%) | 14 (31.1%) | 0.9 |
Reoperation early | 15 (13.3%) | 4 (8.9%) | 0.591 |
Survivors postoperative LOS† | 31.5 (±30.9) | 25.9 (±20.9) | 0.221 |
Mortality | 17 (15.0%) | 2 (4.4%) | 0.101 |
N=158 Patients for whom intraoperative culture data were available.
Survivors N =145.